These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 29797644)

  • 41. Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease.
    Ferraresi M; Panzieri DL; Leoni S; Cappellini MD; Kattamis A; Motta I
    Eur J Pediatr; 2023 Jun; 182(6):2509-2519. PubMed ID: 36997768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
    Rogers ZR
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.
    Raphael JL; Richardson T; Hall M; Oyeku SO; Bundy DG; Kalpatthi RV; Shah SS; Ellison AM
    J Pediatr; 2015 Dec; 167(6):1306-13. PubMed ID: 26470686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dengue in hospitalized children with sickle cell disease: A retrospective cohort study in the French departments of America.
    Elenga N; Celicourt D; Muanza B; Elana G; Hocquelet S; Tarer V; Maillard F; Sibille G; Divialle Doumdo L; Petras M; Tressières B; Etienne-Julan M
    J Infect Public Health; 2020 Feb; 13(2):186-192. PubMed ID: 31548164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-based cohort.
    Quarmyne MO; Dong W; Theodore R; Anand S; Barry V; Adisa O; Buchanan ID; Bost J; Brown RC; Joiner CH; Lane PA
    Am J Hematol; 2017 Jan; 92(1):77-81. PubMed ID: 27761932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of children with sickle cell disease.
    Quinn CT; Rogers ZR; Buchanan GR
    Blood; 2004 Jun; 103(11):4023-7. PubMed ID: 14764527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.
    Estepp JH; Winter B; Johnson M; Smeltzer MP; Howard SC; Hankins JS
    Pediatr Blood Cancer; 2014 Nov; 61(11):2031-6. PubMed ID: 25132074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know.
    Rees AL
    J Pediatr Oncol Nurs; 2016 Sep; 33(5):339-44. PubMed ID: 26611755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
    Couque N; Girard D; Ducrocq R; Boizeau P; Haouari Z; Missud F; Holvoet L; Ithier G; Belloy M; Odièvre MH; Benemou M; Benhaim P; Retali B; Bensaid P; Monier B; Brousse V; Amira R; Orzechowski C; Lesprit E; Mangyanda L; Garrec N; Elion J; Alberti C; Baruchel A; Benkerrou M
    Br J Haematol; 2016 Jun; 173(6):927-37. PubMed ID: 27062606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.
    Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R
    Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospitalisations for sickle-cell disease in an Australian paediatric population.
    Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
    J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.
    Ilerhunmwuwa NP; Inyang L; Wasifuddin M; Aiwuyo H; Tahir M; Hakobyan N; Ankah P; Torere BE; Amaechi UM; Rayapureddy AK; Wang JC
    Eur J Haematol; 2023 Oct; 111(4):611-619. PubMed ID: 37477175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weight status of children with sickle cell disease.
    Chawla A; Sprinz PG; Welch J; Heeney M; Usmani N; Pashankar F; Kavanagh P
    Pediatrics; 2013 Apr; 131(4):e1168-73. PubMed ID: 23460681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Leikin SL; Gallagher D; Kinney TR; Sloane D; Klug P; Rida W
    Pediatrics; 1989 Sep; 84(3):500-8. PubMed ID: 2671914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal effect of disease-modifying therapy on left ventricular diastolic function in children with sickle cell anemia.
    Rai P; Okhomina VI; Kang G; Martinez HR; Hankins JS; Joshi V
    Am J Hematol; 2023 Jun; 98(6):838-847. PubMed ID: 36890729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.